Genmab reported DKK66M in Ordinary Share Capital for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ordinary Share Capital Change
Agios Pharmaceuticals AGIO:US $ 0.07M 0M
Alexion Pharmaceuticals ALXN:US $ 0M 0M
Amarin AMRN:US $ 292.78M 0.42M
Amgen AMGN:US $ 31877M 71M
AstraZeneca AZN:LN 328M 0M
Bayer BAYN:GR € 2515M 0M
Biomarin Pharmaceutical BMRN:US $ 0.18M 0M
Bluebird Bio BLUE:US $ 0.68M 0M
Exelixis EXEL:US $ 0.32M 0M
Galapagos GLPG:NA € 291.91M 0.06M
Genmab GEN:DC DK 66M 0M
GlaxoSmithKline GSK:LN 1347M 1M
GN Store Nord GN:DC DK 553M 16M
GRIFOLS GRF:SM € 119.6M 0M
H. Lundbeck A/S LUN:DC 996M 0
Hikma Pharmaceutical HIK:LN 41M 0
Immunogen IMGN:US $ 2M 0M
Insmed INSM:US $ 1.15M 119K
Lonza Group LONN:SW 74M 0
Merck MRK:GR € 168M 0M
Novartis NOVN:VX SF 913M 0M
Regeneron Pharmaceuticals REGN:US $ 0.1M 0M
Seattle Genetics SGEN:US $ 0.18M 0M
William Demant Holding WDH:DC 48M 0